endocrine · Mechanism Report
Can systemic inflammation and oxidative stress reduce peripheral T4-to-T3 conversion and cause a low T3 pattern in chronic disease?
Systemic inflammation and oxidative stress impair peripheral T4-to-T3 conversion and lead to the low T3 pattern (NTIS) commonly seen in chronic illness.
This is what AI claimed
Systemic inflammation and oxidative stress can reduce peripheral conversion of T4 to T3 and contribute to a low T3 pattern in chronic disease.
Executive summary
The claim states that inflammatory and oxidative processes lower deiodinase activity, decreasing peripheral generation of active T3 and producing the low T3 syndrome in chronic disease. Mechanistically, inflammatory cytokines (e.g., IL-6, TNF-α) activate NF-κB to repress DIO2 transcription, while oxidative stress depletes glutathione, impairing D1 enzyme kinetics and lowering the T3/T4 ratio.
Verified conclusion
The phenomenon of low circulating triiodothyronine (T3) in the presence of normal or low thyroxine (T4) and normal thyroid-stimulating hormone (TSH) is known as non-thyroidal illness syndrome (NTIS) or "low T3 syndrome." This pattern is a highly frequent clinical finding in chronic disease states, where approximately 80% to 90% of circulating T3 is derived from the peripheral conversion of T4.
Mechanistic explanations
Systemic inflammation and oxidative stress act through distinct but synergistic pathways to impair peripheral deiodination:
- Cytokine-Mediated Repression: Inflammatory cytokines, specifically IL-6 and TNF-α, activate the NF-κB signaling pathway. This pathway directly binds to the promoter regions of the DIO2 gene, suppressing its transcription and reducing the availability of the Type 2 deiodinase enzyme responsible for converting T4 to T3.
- Thiol Depletion and Enzyme Kinetics: Type 1 deiodinase (D1), primarily located in the liver and kidneys, requires reduced glutathione (GSH) or other sulfhydryl-containing molecules as essential cofactors for its catalytic cycle. Oxidative stress depletes these intracellular thiol pools; without sufficient GSH, D1 kinetics are impaired, leading to a measurable drop in the T3/T4 ratio.
Clinical evidence
The clinical prevalence of this low T3 pattern is substantial across various chronic pathologies:
- In Chronic Kidney Disease (CKD), studies show a prevalence of low T3 syndrome in approximately 58.7% of patients, where it correlates strongly with markers of systemic inflammation.
- In Acute Myocardial Infarction (AMI) and coronary artery disease, the reduction in T4-to-T3 conversion is used as a significant prognostic marker. Lower T3 levels have been linked to increased mortality and worsened cardiac function (e.g., lower left ventricular ejection fraction).
- In severe systemic conditions like sepsis or ARDS, high levels of circulating cytokines are inversely correlated with serum T3 levels, illustrating the direct impact of the inflammatory load on thyroid hormone metabolism.
Clinical implications
For patients with chronic illness, the low T3 pattern is not merely a biochemical anomaly but a biological marker of disease severity and physiological stress. While the body may initially adopt this state to conserve energy during illness, prolonged suppression of peripheral T3 conversion is associated with poorer clinical outcomes and increased risk of mortality across cardiovascular, renal, and hepatic conditions.
Bottom line
Systemic inflammation and oxidative stress are primary drivers of reduced peripheral T4-to-T3 conversion through the transcriptional repression of deiodinase genes and the depletion of essential glutathione cofactors. This results in a low T3 pattern that serves as a critical prognostic indicator in chronic disease management.
References
- Exploring the mechanism and crosstalk between IL-6 and IL- 1β on M2 macrophages under metabolic stress conditions. — linkinghub.elsevier.com
- Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine‐Mediated Inhibition of Connexin43 Expression — ahajournals.org
- IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome — pnas.org
- The cDNA for the type I iodothyronine 5'-deiodinase encodes an enzyme manifesting both high Km and low Km activity. Evidence that rat liver and kidney contain a single enzyme which converts thyroxine to 3,5,3'-triiodothyronine. — linkinghub.elsevier.com
- [A study of the conversion of thyroxine to 3, 3', 5-triiodothyronine in the rat liver: the mechanism of stimulatory effects of thiols on T4 5'-deiodinase (author's transl)]. — semanticscholar.org
- Effect of selenium depletion and supplementation on the kinetics of type 1 5′-iodothyronine deiodinase and T3/T4 in rats — link.springer.com
- Type 2 iodothyronine deiodinase is essential for thyroid hormone-dependent embryonic development and pigmentation in zebrafish. — academic.oup.com
- The thyroid hormone activating enzyme, type 2 deiodinase, induces myogenic differentiation by regulating mitochondrial metabolism and reducing oxidative stress — linkinghub.elsevier.com
- Thyroid function in critically ill patients. — pmc.ncbi.nlm.nih.gov
- New Insights toward the Acute Non-Thyroidal Illness Syndrome — pmc.ncbi.nlm.nih.gov
- Hypovitaminosis D and Low T3 Syndrome: A Link for Therapeutic Challenges in Patients with Acute Myocardial Infarction — mdpi.com
- Glutathione-dependent thyroxine 5'-monodeiodination modulates growth hormone production by cultured nonthyrotropic rat pituitary cells. — academic.oup.com
- Disturbances in Thyroid Hormone Metabolism in Rats Exposed to γ- Radiation and Carbon Tetrachloride: The Role of N- acetyl cysteine and Sodium Selenite — ejrsa.journals.ekb.eg
See a full patient report verified like this
Book a walkthrough